Key result
Cardiometabolic risk (P=0.0159), rather than obesity (P=0.1446), was significantly associated with the development of subclinical atherosclerosis in Mexican-Americans.
Why the study?
Is cardiometabolic risk or obesity more strongly associated with subclinical atherosclerosis in Mexican-Americans?
Cohort (n=503)
Is cardiometabolic risk or obesity more strongly associated with subclinical atherosclerosis in Mexican-Americans?
p-value: p=0.0159
Cardiometabolic risk factors, rather than BMI alone, drive early atherosclerosis development in Mexican-Americans, highlighting the importance of targeting metabolic health over weight loss alone.
May prioritize cardiometabolic risk management over BMI alone in Mexican-Americans; leaves open causal effects and intervention benefits.
BACKGROUND: Data on the influence of obesity on atherosclerosis in Hispanics are inconsistent, possibly related to varying cardiometabolic risk among obese individuals. We aimed to determine the association of obesity and cardiometabolic risk with subclinical atherosclerosis in Mexican-Americans. METHODS AND RESULTS: Participants (n=503) were drawn from the Cameron County Hispanic Cohort. Metabolic health was defined as <2 of the following: blood pressure ≥130/85; triglyceride ≥150 mg/dL; high-density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women); fasting glucose ≥100 mg/dL; homeostasis model assessment of insulin resistance value >5.13; or high-sensitivity C-reactive protein >3 mg/L. Carotid intima media thickness (cIMT) was measured. A high proportion of participants (77.8%) were metabolically unhealthy; they were more likely to be male, older, with fewer years of education, and less likely to meet daily recommendations regarding fruit and vegetable servings. One-third (31.8%) had abnormal carotid ultrasound findings. After adjusting for covariates, mean cIMT varied across the obesity phenotypes (P=0.0001); there was no difference among the metabolically unhealthy regardless of whether they were obese or not. In multivariable analysis, after adjusting for covariates, cardiometabolic risk (P=0.0159), but not obesity (P=0.1446), was significantly associated with subclinical atherosclerosis. CONCLUSIONS: In Mexican-Americans, cardiometabolic risk has a greater effect on early atherosclerosis development than body mass index. Non-obese but metabolically unhealthy participants had similar development of subclinical atherosclerosis as their obese counterparts. Interventions to maintain metabolic health among obese and non-obese patients may be a more important goal than weight loss alone.
No takes yet. Share an insight, caveat, or question.
Laing et al. (2015) conducted a cohort in Subclinical atherosclerosis and obesity (n=503). Cardiometabolic risk and obesity phenotypes vs. Metabolically healthy and non-obese phenotypes was evaluated on Subclinical atherosclerosis (carotid intima media thickness) (p=0.0159). Cardiometabolic risk (P=0.0159), rather than obesity (P=0.1446), was significantly associated with the development of subclinical atherosclerosis in Mexican-Americans.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: